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Background: The parallel-group randomized active-controlled clinical study was conducted to compare the
effectiveness of two in-hospital range of motion (ROM) exercise programs following total knee arthroplasty (TKA).
Continuous passive motion (CPM) is frequently used to increase ROM and improve postoperative recovery despite
little conclusive scientific evidence. In contrast, a new active sling-based ROM therapy requires the activation of the
knee joint muscles and dynamic joint stabilization. It was hypothesized that higher demands on muscle strength and
muscle coordination during sling exercise training (ST) might be advantageous for early recovery following TKA.
Methods: A total of 125 patients undergoing primary TKA were assessed for eligibility. Thirty-eight patients were
randomly assigned to receive ST or CPM (control intervention) during hospital stay. Patients were assessed before
TKA for baseline measurement (pretest), 1 day before discharge (posttest) and 3 months after TKA (follow-up). The
passive knee flexion range of motion (pFL) was the primary outcome measure. Secondary outcome measures included
active knee flexion range of motion, active and passive knee extension ROM, static postural control, physical activity,
pain, length of hospital stay as well as clinical, functional and quality-of-life outcomes (SF-36, HSS and WOMAC scores).
Data were analyzed according to the intention-to-treat principle. Differences between the groups were tested for
significance by the unpaired Student’s t test or an analysis of covariance (ANCOVA) adjusted for baseline, weight, sex,
age, pain and physical activity.
Results: A between-group difference could be determined at posttest. The pFL was significantly higher by 6.0°
(95% CI 0.9 to 11.2°; P = 0.022) in the ST group. No difference between groups in pFL was documented at follow-up.
Furthermore, no significant differences could be observed for any secondary outcome measure at posttest and
follow-up.
Conclusions: ST seems to have a clinically relevant beneficial short-term effect on pFL compared to CPM. The results
support the implementation of ST in rehabilitation programs following TKA.
Level of evidence: Therapy, level 2b
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The major objectives of rehabilitation after total knee
arthroplasty (TKA) are the early regain of range of motion
(ROM) and mobilization of the patient. Continuous
passive motion (CPM) has been frequently used as part of
the postoperative care regime following TKA with the aim
to increase knee joint mobility and improve postoperative
recovery despite little conclusive scientific evidence [1-4].
Conflicting research findings have generated an ongoing
debate on its usage. The evidence for the effects on pain
[5,6], function [5,7], length of hospital stay [8,9], swelling
[6,10] and quadriceps strength [5,11] is inconclusive. The
Cochrane Review of Harvey et al. reported evidence for
small short-term effects of CPM on active and passive
knee flexion ROM (aFL, pFL) of 2° and 3° [1]. The ROM
is a primary indicator of a successful TKA [12] and is
directly related to function [13]. Adequate knee flexion up
to 90-120° is required for activities of daily living such as sit
to stand transfers and climbing stairs [13]. Consequently,
most research on the effectiveness of CPM focuses on
ROM as the primary outcome variable [5,7,14-18].
The attainment of at least 0-90° ROM is the goal upon
hospital discharge and a more functional range of 0-120°
should be attained upon completion of postoperative
physiotherapy. Nevertheless, Harvey et al. suggested that
the beneficial effects of CPM on ROM are too small
to be practically relevant. Clinically meaningful differ-
ences between standard physiotherapy and standard
physiotherapy combined with CPM are reported to be
at least 5° [1].
As the greatest loss of function occurs in the first
month following TKA [19], it is surprising that the
ROM therapy during hospital stay is still carried out
passively. A passive mobilization of the knee joint
with CPM does not encourage the patients to actively
participate in their rehabilitation. Research on the
effectiveness of active ROM exercises added to standard
physiotherapy during the short in-hospital period is
lacking so far. Only two studies have investigated an
adjunctive active motion therapy by comparing it to
patients treated with physiotherapy plus CPM and to
patients treated only with physiotherapy [17,20]. Group
differences were not reported, indicating that an ad-
junctive active ROM therapy has no benefit for patients’
recovery. However, it should be taken into account that
knee joint mobilization exercises using passive or active
motion machines are guided movements and are therefore
less functional.
The present randomized clinical study was conducted
to compare a new active sling-based in-hospital ROM
exercise program with the standard-of-care therapy
(CPM) following TKA. Sling exercises are self-induced
and non-guided movements with unstable support which
require the activation of muscles and dynamic knee jointstabilization. It was assumed that higher demands on
muscle strength and muscle coordination during ST
might be advantageous for early recovery following
TKA
Whether an early postoperative application of ST could
be beneficial for postoperative ROM, pain, physical activity,
static postural control, length of hospital stay as well as
clinical, functional and quality-of-life outcomes compared
to CPM therapy was analyzed.
Methods
The two arm parallel-group superiority randomized
active-controlled clinical study was conducted from
January 2011 to April 2012 and approved by the Ethical
Review Commitee of the University Medicine Rostock
(A 2009 25).
Eligible participants were patients undergoing primary
TKA for osteoarthritis aged 50 to 80 years with a body
mass index (BMI) less than 40. Patients with contralate-
ral TKA or total hip arthroplasty were included when
the surgery was performed more than one year before
the current TKA. Exclusion criteria were as follows:
musculoskeletal and neurological disorders that limit
physical function, any planned further joint surgery
within 12 months and substantial pain or functional
limitation which made the patients unable to perform
the study procedures. Prior to participation, written
informed consent was obtained from all participants.
Afterwards, eligible patients were randomly assigned to
one of two treatment groups using blocked randomization
by a computer-generated table of random numbers, a
block size of ten and an allocation ratio of 1:1. Participants
were sequentially allocated to the treatments in the order
in which they were recruited. Intervention assignment
was ascertained using sealed, opaque envelopes with
consecutive numbering after the enrolled patients com-
pleted all baseline measurements. The investigator who
opened the envelopes and carried out the implementation
of assignments was not involved in the generation and
allocation concealment. Outcome investigators and partic-
ipants were blinded to the treatment at baseline measure-
ments. Afterwards, participants and physiotherapists were
aware of the group allocation due to the nature of the
intervention.
All patients underwent a standard surgical procedure
by inserting the same implant (Multigen Plus, Lima-Lto,
San Daniele, Italy) with an identical surgical approach.
Postoperatively they received continuous peridural analgesia
or femoral nerve block. Additionally, a 3-step analgesia
was performed to provide optimal pain relief with (1)
indomethacin (25 mg), (2) metamizol and (3) paracetamol.
The Multigen Plus implant is a non-constrained surface
replacement consisting of symmetrical, cruciate-retaining,
cemented metallic femoral and tibial components and
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liners. All patients underwent full-weight-bearing with
two crutches beginning on the second postoperative day.
Interventions
Eligible patients were either allocated to (a) the CPM
group, which received physiotherapy and CPM application
(control intervention; standard-of-care therapy) or (b) the
ST group, which received physiotherapy and performed
sling exercises. All patients participated in a standardized
in-hospital physiotherapy which was carried out by phys-
ical therapists twice a day for 30 minutes each, starting on
the first postoperative day. Physiotherapy consisted of ac-
tive and passive ROM exercises, active isometric contrac-
tions of the quadriceps and exercises to improve activities
of daily living like transfer from bed to chair, transition
from sitting to standing, walking and climbing stairs. Exer-
cise intensity was gradually increased according to pain
and tolerance. Furthermore, patients received two 30 mi-
nutes CPM or ST applications each day from the second
postoperative day until 1 day prior to discharge. The
patients were shown the CPM or the ST exercises by a
physiotherapist.
The CPM protocol was started with 0° to the maximum
tolerated flexion at the highest, adjustable speed. ROM
was increased daily depending on tolerance. The CPM
machines used were Kinetec® OptimaTM S3 and S4
(AbilityOne Kinetec S.A., Tournes, France) with maximal
possible flexion angles of 115° and 120°. Participants were
instructed not to resist or actively support the motion of
the device.
The participants in the ST group performed active
knee flexions and extensions in a sling while lying in a
supine position. The sling exercise intervention is shown
in Figure 1. The patient’s leg was placed in a standard
tubular bandage that was suspended from a cross brace
fixed to the bed. The ST protocol was started with 0°Figure 1 Sling exercise training.to maximum tolerated flexion at a movement speed
comparable to those used in the CPM protocol. Exercise
progression was achieved by asking the patients to
gradually increase the range of motion as tolerated.
Patients were discharged when sufficiently mobile (i.e.,
at least 90° knee flexion and no need of personal care) and
medically stable. After discharge, all patients participated
in daily physical therapy for 3 weeks in a rehabilitation
hospital.
Outcomes
Participants were assessed before TKA for baseline
measurement (pretest), 1 day before discharge (posttest)
and 3 months after TKA (follow-up). The pFL was the
primary outcome measure. Secondary outcome measures
included aFL as well as active and passive knee extension
ROM (aEX, pEX), static postural control, physical activity,
pain and length of hospital stay. Furthermore, clinical,
functional and quality-of-life outcomes were evaluated
(i.e., SF-36, HSS and WOMAC scores). Any outcomes
were determined by the same investigator. Table 1 shows
the methods and parameters.
Range of motion (ROM)
Active and passive ROM (aFL, pFL, aEX and pEX) were
measured using a standard handheld goniometer with
the patient in a supine position [21]. The goniometer
was placed over the joint space with one arm in line
with the fibular head and lateral malleolus and the other
aligned with the greater trochanter. The knee was flexed
maximally and the angle was measured in degrees. Knee
extension was measured in the same position as for
flexion. The knee was moved to maximal extension and
the angle was measured. Jakobsen et al. (2010) showed
substantial inter-tester and intra-tester reliability of
the knee joint ROM measurement in patients with
TKA [22].








Physical activity Activity monitor
Static postural control Force plate
Length of hospital stay
Pain Visual analogue scale
Clinical, functional and quality-of-life
outcomes
HSS, SF-36 and WOMAC
scores
Abbreviations: pFL, maximal passive knee flexion; aFL, maximal active knee
flexion; aEx, maximal active knee extension; pEx, maximal passive knee
extension; HSS score, Hospital for Special Surgery Score; SF-36, Short Form
Health Survey; WOMAC score, Western Ontario and McMaster
Osteoarthritis Score.
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Pain was evaluated using a 10 cm visual analog scale
(VAS). Patients were asked to mark their degree of knee
pain on a continuous horizontal line whereby the very
left end indicated no pain (score 0) and the very right end
(score 10) indicated unbearable pain. Studies have shown
that the VAS is more reliable than the questionnaires in
patients with TKA [23].
Physical activity
Physical activity was determined with an accelerometer-
based mobility monitoring device (activPALTM, PAL
Technologies Ltd., Glasgow, UK) [24]. The activity
monitor was attached to the thigh anteriorly in the
middle between the knee and the hip. Physical activity
was monitored during hospital stay over a period of
5 days (fourth to eighth day) and 3 months postoperatively
for 7 days. During hospital stay the sensor was applied to
the thigh of the un-operated leg to preclude measurement
errors due to intervention-related joint mobilization.
At the follow-up the sensor was fixed to the right
thigh. Participants were instructed to wear the device
permanently except when performing water activities
(e. g., taking a shower, swimming). The absolute time spent
lying/sitting, standing and stepping as well as the number
of steps and sit to stand transitions were measured. Data
were obtained with a sampling frequency of 10 Hz and
analyzed with the activPALTM interface program.
Static postural control
The participants executed postural tasks in upright bipedal
stance on a force plate (GKS 1000®, IMM Holding GmbH,
Mittweida, Germany) in static condition. The force platemeasured the trajectory of the center of pressure (CoP) in
medio-lateral (m-l) and anterior-posterior (a-p) direction.
Participants were asked to stand as stable as possible, in
slight knee flexion and with hands akimbo. The position of
feet was marked for repeated testing. Two conditions of
vision were tested: (1) eyes open, (2) eyes closed. In the
eyes-open condition, the participants were instructed to
fixate a black point (Ø 10 cm) located 1.20 m away from
the platform at eye level. In the eyes-closed condition, they
were instructed to close their eyes and maintain the gaze
straight ahead. In order to become familiar with the
procedure the participants completed three pre-trials.
Thereafter, three test trials each of 15 seconds duration
were performed. Before the recording of measurement was
started, patients had to stabilize stance for 10 seconds. A
rest period of 1 minute was allowed between the trials.
Data were obtained with a sampling frequency of 40 Hz
and analyzed with the GKS-MED Software (IMM Holding
GmbH, Mittweida, Germany) und Excel 2007 (Microsoft
Inc., Seattle, USA). The velocity and sway of the CoP
displacement in m-l and a-p direction (velocitym-l,
velocitya-p, swaym-l, swaya-p) and the area of the CoP
displacement were evaluated. The mean value of the
three test trials was used for further analyses.
Clinical, functional and quality-of-life outcomes
Health-related status, function and quality of life were
evaluated using the 36-item Short Form Health Survey
(SF-36) [25], Hospital for Special Surgery Knee Score
(HSS) [26], and Western Ontario and McMaster University
Osteoarthritis Index (WOMAC) [27]. The scores are
generally acknowledged to have good reliability and validity
[25,27,28]. Each scale ranges from 0 (poorest status) to 100
points (best status). The SF-36 consists of 36 items
assigned to 8 subscales: physical functioning, physical role,
bodily pain, general health, vitality, social functioning,
emotional role and mental health. Two summary scores
(mental and physical health) and one total score were
calculated as the mean of the 8 subscales. The WOMAC
score is a disease-specific, self- administered, health status
measure using 3 subscales with a total of 24 items:
pain (5 items), function (17 items) and stiffness (2 items).
Each question was answered using a 5-point Likert scale.
The HSS score is subdivided into six categories: pain,
function, range of motion, muscle strength, flexion
deformity and instability.
Statistical analysis
There are no preliminary studies on the comparison of
both interventions. Based on the review of Harvey et al.
(2010) and with the aim of showing clinically relevant
differences, we hypothesized a difference in ROM between
ST and CPM therapy of 5° [1]. Sample size calculation in-
dicated that a total of 52 patients would be required to
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significance of 0.05 and a power of 0.80. In considering an
anticipated dropout rate of 10%, a total of 58 patients were
needed for the trial. A 14-month recruitment period was
assumed to enroll this number of participants.
Data analysis included all randomized patients according
to their original treatment allocation (intention-to-treat
analysis) [29]. Data were checked for normal distribution
using the Shapiro-Wilk W Test. Non-normally distributed
data were log-transformed before analysis. Multiple imput-
ation (5 imputed data sets) was used to account for missing
data using the Markov Chain Monte Carlo (MCMC)
method [30]. Differences between the groups were tested
for significance by the unpaired Student’s t test (P ≤ 0.050)
or an analysis of covariance (ANCOVA) adjusted for
baseline [31], weight, sex, age, pain and physical acti-
vity (alpha-adjustment for conducting two ANCOVA’s
P ≤ 0.050/2 = 0.025). All data were analyzed using the
SPSS statistical package (version 20.0, SPSS Inc., Chicago,Figure 2 CONSORT flow diagram to show the flow of participants thrIL, USA). Sample size, power and Cohen’s effect size were
calculated with the statistical software package G*Power
(version 3.1.4.) [32]. The effect size f was interpreted using
the classification of Cohen (1988): f = 0.10 small effect,
f = 0.25 medium effect, f = 0.40 large effect [33].
Data of the pretest are presented as mean and standard
deviation in the tables. Pooled multiple imputation data of
each primary and secondary outcome are reported as
covariate-adjusted means and standard deviation together
with the effect size (mean difference) and its precision (95%
confidence intervals, 95% CI) in the figures and tables.
Results
Thirty-eight participants were recruited from 125 available
patients within the 14 month recruitment period. The
recruitment of patients was stopped when the scheduled
date of closure was reached. The minimum sample size
(N = 58) required was not achieved. Recruitment numbers,
reasons for not being eligible or enrolled as well asough the trial [34].
Table 2 Baseline demographic and clinical subject
characteristics
Variable ST CPM
(n = 19) (n = 19)
Age, yrs 68.8 (8.0) 67.1 (8.8)
Sex, men 12.0 (63.2%) 10.0 (52.6%)
Weight, kg 88.9 (13.3) 93.6 (15.9)
Height, m 1.69 (0.1) 1.68 (0.1)
BMI 31.1 (4.2) 33.3 (5.1)
Affected side, right 8.0 (42.1%) 7.0 (36.8%)
Hypertension 13.0 (68.4%) 14.0 (73.7%)
Cardiac problems 6.0 (31.6%) 5.0 (26.3%)
Pulmonary problems 1.0 (5.3%) 0.0 (0%)
Diabetes 2.0 (10.5%) 5.0 (26.3%)
Cancer 1.0 (5.3%) 0.0 (0%)
TKA contralateral side 5.0 (26.3%) 6.0 (31.6%)
THA contralateral side 2.0 (10.5%) 0.0 (0%)
THA ispilateral side 3.0 (15.8%) 1.0 (5.3%)
Abbreviations: ST, sling exercise training group; CPM, continuous passive
motion group; BMI, body mass index; TKA, total knee arthroplasty; THA, total
hip arthroplasty.
Values are presented as mean (standard deviation) or numbers (%).
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reported in the CONSORT flow diagram (Figure 2). The
patients’ demographic and clinical characteristics are
displayed in Table 2. All patients received an allocated
intervention and were analyzed for outcome measures.
Both groups did not differ significantly in the number of
physiotherapy, CPM and ST interventions and in the time
to posttest and follow-up (Table 3). No incidents of adverse
effects or harm during the study could be observed.Primary outcome
A between-group difference could be determined at post-
test. The pFL was significantly higher by 6.0° (F = 5,80;
P = 0.022; ηp
2 = 0.162; f = 0.440) in the ST group.Table 3 Number of interventions during hospital stay and tim
Variable ST
(n = 19)
CPM or ST, n 14.2 (2.2)
Standard physiotherapy, n 8.1 (1.0)
Gait training, n 6.4 (1.3)
Start day of walking corridor‡ 4.0 (1.2)
Start day of climbing stairs‡ 7.5 (1.6)
Postest, d 9.6 (1.3)
Follow-up, d 95.5 (9.7)
Abbreviations: ST, sling exercise training group; CPM, continuous passive motion gro
‡ANCOVA: adjusted for sex, weight, age, pain and physical activity.
Values are presented as means (standard deviation).No difference in pFL was documented at follow-up
(Table 4; Figure 3).Secondary outcomes
No significant differences between the groups could
be observed for any secondary outcome measure at
posttest and follow-up (Tables 4, 5, 6). However, a
statistical tendency toward an increase in aFL by 4.4°
(F = 3.53; P = 0.070; ηp
2 = 0.105; f = 0.343; Power = 0.533)
could be documented for the ST group (Table 4; Figure 3).
Furthermore, the velocitya-p for the eyes closed condition
tended to be higher by 4.5 mm∙s-1 (F = 4.66; P = 0.040;
ηp
2 = 0.143; f = 0.480; Power = 0.683) and the HSS score
demonstrated a trend toward lower muscle strength by
−0.9 (F = 4.20; P = 0.049; ηp
2 = 0.116; f = 0.362; Power
= 0.582) in the ST group at posttest (Tables 4, 6).Discussion
The objective of the present randomized clinical study was
to compare the effectiveness of a new sling-based ROM
therapy with the traditional CPM application as an adjunct
to daily physiotherapy following TKA. The knee joint
mobilization in the sling requires the activation of muscles.
Furthermore, the unstable support during the performance
of ROM exercises might contribute to higher demands on
muscle strength and muscle coordination. Therefore, it
was assumed that an ST might be advantageous for early
recovery following TKA.
There is evidence that ST has a significant positive,
short-term effect on pFL of 6°. A medium-term benefit
of these positive effects on knee flexion ROM could not be
confirmed because no differences between groups were
determined at the 3-month follow-up. Furthermore, there
were no significant beneficial effects of ST on the secondary
outcomes (aFL, aEX, pEX, pain, physical activity, static
postural control, length of hospital stay and health-related
status, function or quality of life).e to posttest and follow-up
CPM Mean difference P
(n = 19) (95% CI)
14.6 (1.8) −0.46 (−1.8, 0.89) 0.597
8.4 (0.7) −0.32 (0.29, −0.90) 0.281
6.6 (1.0) −0.26 (−1.00, 0.47) 0.472
4.3 (1.2) −0.31 (−1.10, 0.49) 0.437
7.5 (1.6) <0.01 (−0.99, 0.99) 0.997
9.5 (0.6) 0.06 (−0.67, 0.78) 0.870
90.7 (8.7) 4.77 (−2.89, 12.44) 0.212
up.
Table 4 Outcome measures of knee joint range of motion and static postural control with open and closed eyes
Pretest Posttest‡ Follow-up‡
Variable ST CPM ST CPM Mean difference ST CPM Mean difference
(n = 19) (n = 19) (n = 19) (n = 19) (95% CI) (n = 19) (n = 19) (95% CI)
Range of motion
Active flexion, ° 108.4 (15.1) 103.0 (21.7) 91.8 (6.9) 87.4 (6.9) 4.4 (−0.4, 9.1)† 101.4 (9.6) 103.3 (9.6) −1.9 (−8.5, 4.7)
Passive flexion, ° 111.6 (13.7) 106.1 (20.2) 95.3 (7.4) 89.2 (7.4) 6.0 (0.9, 11.2)* 104.1 (8.6) 107.1 (8.6) −3.0 (−8.9, 2.9)
Active extension, ° 4.5 (5.2) 3.4 (6.7) 1.6 (3.2) 1.7 (3.2) −0.1 (−2.3, 2.1) 3.8 (5.4) 2.0 (5.4) 1.8 (−1.9, 5.4)
Passive extension, ° 3.6 (4.0) 3.4 (5.5) 0.7 (1.6) <0.1 (1.6) 0.7 (−0.4, 1.8) 2.8 (4.1) 0.8 (4.1) 2.0 (−0.8, 3.8)
Postural control – eyes open
Area, cm2 1.50 (0.52) 1.47 (0.92) 1.63 (0.83) 1.62 (0.83) 0.01 (−0.54, 0.56) 1.42 (0.62) 1.44 (0.62) −0.03 (−0.43, 0.38)
Swaym-l, mm 5.33 (2.46) 4.84 (1.77) 6.61 (2.73) 7.29 (2.73) −0.68 (−2.50, 1.14) 6.25 (2.18) 6.12 (2.18) 0.13 (−1.30, 1.56)
Swaya-p, mm 5.66 (2.22) 4.99 (1.64) 8.77 (4.11) 7.86 (4.11) 0.92 (−1.82, 3.66) 7.29 (2.95) 6.17 (2.95) 1.12 (−0.83, 3.07)
Velocitym-l, mm∙s−1 11.32 (2.66) 11.55 (4.78) 17.87 (7.59) 18.03 (7.59) −0.17 (−5.19, 4.86) 15.70 (8.59) 18.32 (8.59) −2.62 (−8.26, 3.02)
Velocitya-p, mm∙s−1 12.53 (3.09) 11.89 (3.40) 24.39 (8.72) 22.39 (8.72) 2.00 (−3.80, 7.79) 19.64 (8.00) 20.13 (8.00) −0.48 (−5.74, 4.77)
Postural control – eyes closed
Area. cm2 3.24 (2.11) 4.16 (3.39) 3.83 (1.41) 3.23 (1.41) 0.59 (−0.35, 1.53) 3.19 (2.09) 3.68 (2.09) −0.49 (−1.87, 0.89)
Swaym-l, mm 6.30 (2.08) 6.90 (2.28) 6.84 (2.55) 7.13 (2.55) −0.29 (−1.98, 1.40) 6.36 (2.01) 6.03 (2.01) 0.32 (−1.00, 1.64)
Swaya-p, mm 7.33 (2.65) 8.29 (4.76) 9.12 (3.98) 7.54 (3.98) 1.58 (−1.05, 4.22) 7.99 (2.31) 7.33 (2.31) 0.66 (−0.86, 2.18)
Velocitym-l, mm∙s−1 16.54 (5.48) 19.10 (11.70) 18.61 (5.59) 17.37 (5.59) 1.23 (−2.47, 4.94) 16.95 (7.25) 17.20 (7.25) −0.25 (−5.04, 4.54)
Velocitya-p, mm∙s−1 19.34 (5.58) 21.63 (14.36) 25.71 (6.44) 21.21 (6.44) 4.50 (0.23, 8.77)† 20.44 (6.66) 19.41 (6.66) 1.03(−3.36, 5.42)
Abbreviations: ST, sling exercise training group; CPM, continuous passive motion group; m-l, medio-lateral; a-p, anterior-posterior.
*denotes a significant difference (P ≤ 0.025); †denotes a statistical tendency (P ≤ 0.100). ‡ANCOVA: values of the posttest were adjusted for baseline, sex, weight,
age, pain and physical activity; values of the follow-up-measurement were adjusted for baseline, sex, weight, age and physical activity.
Values of the pretest are presented as mean (standard deviation). Values of the posttest and follow-up-measurement are presented as estimated marginal means
(standard deviation).
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CPM therapy compared to physiotherapy alone reported
short-term effects on aFL and pFL by 3° and 2°, respectively
[1]. The authors suggested that these effects on ROM are
too small to be clinically relevant. Taking into account the
fact that the application of CPM is associated with
high costs for the rental or acquisition of the device
and additional technical and personnel efforts to set
up and operate the machine, it was suggested that an
additional ROM of more than 5° is required to justify itsFigure 3 The Graphs show the comparisons between the groups. A. P
ROM. The dark grey line represents the sling exercise training group (ST) an
are presented as estimated marginal means and standard deviation (ANCO
activity; follow-up adjusted for baseline, sex, weight, age and physical activuse [1]. Following this recommendation, we hypothesized a
clinically relevant mean difference in ROM of 5° between
ST and CPM therapy. Our present data demonstrate a
between-group difference in pFL of 6°, which is above
the hypothesized and clinically relevant difference.
This result leads to the assumption that the application of
an adjunctive ST therapy in the early postoperative phase
could be recommended as a part of the rehabilitation
program following TKA. Nevertheless, the clinical
relevance remains uncertain as the confidence intervalassive knee flexion range of motion (ROM). B. Active knee flexion
d the light grey line the continuous passive motion group (CPM). Data
VA: posttest adjusted for baseline, sex, weight, age, pain and physical
ity. * denotes a significant difference (P ≤ 0.025).
Table 5 Outcome measures for pain and physical activity
Pretest Posttest‡ Follow-up‡
Parameter ST CPM ST CPM Mean difference ST CPM Mean difference
(n = 19) (n = 19) (n = 19) (n = 19) (95% CI) (n = 19) (n = 19) (95% CI)
Pain n/a n/a 1.22 (1.73) 1.78 (1.73) −0.56 (−1.73, 0.60) n/a n/a n/a
Length of hospital stay, d 9.99 (0.31) 10.52 (0.32) −0.53 (−1.47, 0.41)
Physical activity
Lying/sitting, h n/a n/a 112.0 (3.4) 111.5 (3.4) 0.5 (−1.8, 2.8) 134.4 (9.1) 132.3 (9.1) 2.2 (−4.0, 8.2)
Standing, h n/a n/a 7.1 (2.7) 6.1 (2.7) 1.0 (−0.8, 2.8) 25.3 (6.0) 25.5 (6.0) −0.2 (−4.2, 3.8)
Stepping, h n/a n/a 1.4 (0.80) 1.3 (0.80) 0.1 (−0.5, 0.6) 9.5 (3.6) 9.4 (3.6) 0.1 (−2.3, 2.6)
Sit to stand transition, n n/a n/a 156.4 (56.3) 129.2 (56.3) 27.2 (−10.9, 65.2) 330.5 (102.4) 320.8 (102.4) 9.7 (−59.0, 78.4)
Step count, n n/a n/a 4685 (3087) 4151 (3087) 534 (−1555, 2624) 42037 (14412) 36203 (14412) 5834 (−3836, 15504)
Abbreviations: ST, sling exercise training group; CPM, continuous passive motion group; n/a, not available.
‡ANCOVA: pain was adjusted for sex, weight, age and physical activity; length of hospital stay was adjusted for sex, weight, age, pain and physical activity;
the posttest-values of physical activity were adjusted for sex, weight, age and the follow-up-values were adjusted for sex, weight and age.
Values are presented as estimated marginal means (standard deviation).
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have to be considered.
Study limitations
Our study was limited by the small sample size. The target
number of participants was not achieved by the scheduledTable 6 Outcome measures of clinical, functional and quality-
Pretest Posttes
Variable ST CPM ST CPM
(n = 19) (n = 19) (n = 19) (n = 19)
HSS score, %
Pain 10.8 (6.9) 14.5 (7.4) 24.3 (6.4) 22.3 (6.4)
Function 13.7 (4.1) 15.1 (4.2) 9.7 (3.4) 10.0 (3.4)
Strength 10.0 (0.0) 9.9 (0.5) 8.9 (1.3) 9.7 (1.3)
Instability 9.6 (1.2) 9.6 (1.2) 10.0 (0.0) 10.0 (0.0)
FlexDeform 9.1 (1.9) 8.7 (2.3) 10.0 (0.0) 10.0 (0.0)
ROM 13.9 (1.6) 13.1 (2.4) 12.3 (1.0) 11.5 (1.0)
Total 66.3 (11.8) 69.9 (11.8) 71.6 (9.7) 70.8 (9.7)
SF-36 score, %
Physical health 32.9 (16.2) 30.3 (13.5) 40.0 (14.0) 37.6 (14.0)
Mental health 66.3 (19.8) 57.8 (20.5) 68.1 (18.1) 66.2 (18.1)
Total 49.9 (15.1) 44.0 (15.4) 50.9 (14.3) 52.3 (14.3)
WOMAC score, %
Pain 8.9 (3.3) 9.5 (3.9) 15.2 (3.7) 14.9 (3.7)
Stiffness 4.6 (2.0) 4.0 (1.9) 6.0 (1.5) 6.4 (1.5)
FD 32.3 (9.2) 34.7 (8.7) 44.9 (12.9) 43.7 (12.9)
Total 47.9 (13.6) 46.8 (18.2) 69.6 (18.1) 67.3 (18.1)
Abbreviations: ST, sling exercise training group; CPM, continuous passive motion gro
deformity; ROM, range of motion; SF-36, Short Form Health Survey; WOMAC score,
functional difficulty.
*denotes a significant difference (P ≤ 0.025); †denotes a statistical tendency (P ≤ 0.10
Values of the pretest are presented as mean (standard deviation). Values of the pos
(standard deviation).day of closure due to an unexpectedly low number of
patients that met the inclusion criteria. It was not possible
to extend the study to achieve adequate enrollment, as the
date of termination of financial support of the project had
been reached. The high proportion of ineligibility reduces
the generalizability of the findings. A post-hoc powerof-life outcomes
t‡ Follow-up‡
Mean difference ST CPM Mean difference
(95% CI) (n = 19) (n = 19) (95% CI)
1.9 (−2.5, 6.4) 23.1 (6.1) 20.9 (6.1) 2.2 (−2.0, 6.4)
−0.3 (−2.6, 2.0) 16.7 (3.1) 17.7 (3.1) −1.1 (−3.2, 1.1)
−0.9 (−1.7, 0.0)† 10.0 (0.0) 10.0 (0.0) -
- 10.0 (0.0) 10.0 (0.0) -
- 10.0 (0.0) 10.0 (0.0) -
0.8 (0.2, 1.5)* 12.7 (1.8) 12.9 (1.8) −0.2 (−1.4, 1.1)
0.8 (−5.8, 7.4) 81.6 (10.2) 79.2 (10.2) 2.4 (−4.5, 9.4)
2.5 (−6.9, 11.9) 52.5 (19.7) 52.6 (19.7) 0.1 (−13.3, 13.2)
1.6 (−10.6, 13.9) 72.7 (18.2) 69.4 (18.2) 3.2 (−9.0, 15.6)
−1.4 (−11.1, 8.3) 63.5 (16.3) 61.3 (16.3) 2.2 (−8.8, 13.2)
0.3 (−2.2, 2.8) 15.2 (3.6) 14.7 (3.6) 0.42 (−2.03, 2.87)
−0.4 (−1.4, 0.6) 5.5 (1.6) 5.1 (1.6) 0.31 (−0.75, 1.37)
1.2 (−7.5, 9.9) 49.4 (8.3) 47.2 (8.3) 2.22 (−3.40, 7.83)
2.3 (−9.8, 14.4) 73.2 (12.5) 67.7 (12.5) 5.51 (−2.83, 13.86)
up; HSS score, Hospital for Special Surgery Knee Score; FlexDeform, flexion
Western Ontario and McMaster University Osteoarthritis Score; FD,
0). ‡ANCOVA: adjusted for baseline, sex, weight and age.
ttest and follow-up-measurement are presented as estimated marginal means
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did not reach statistical significance in order to rule in or
rule out inadequate power as a threat to the internal valid-
ity of the findings [35]. The post-hoc power coefficients
were low (power < 0.80). Thus, the study was under-
powered for many outcome variables and a lack of power,
possibly due to small sample size, is an alternative ex-
planation of the statistically non-significant findings. It
could be assumed that, if the study had been adequately
powered we could have seen a greater number of statisti-
cally significant differences.
A second limitation was the 26% dropout rate at the
3-month follow-up. However, none of the patients
withdrew from the study for a reason related to the
study treatment. Missing values will result in a reduction
of the number of cases for analysis which reduces
precision and possibly introduces bias. The missing-data
problem was handled by imputing missing values using
multiple imputation [29,30].
A further limitation was the inability to blind the patients
and practitioners, which was impossible due to the nature
of the intervention. Although it would be appropriate, it
was not possible to run a 3-arm trial including an arm with
no additional intervention because CPM combined with
usual physiotherapy is the standard treatment following
TKA in the Department of Orthopedics at the University
Medicine Rostock. Thus, it was not considered appropriate
to exclude the CPM therapy.
Despite these limitations, a statistically significant and
clinically relevant positive result relating to the ST therapy
could be presented.
Conclusions
This study was the first randomized controlled trial to
systematically assess the effectiveness of a new active
sling-based in-hospital ROM exercise program with the
standard-of-care therapy (CPM) following TKA. Findings
in the literature indicate that an adjunctive passive ROM
therapy using CPM only slightly contributes to an initial
regain of ROM. The present data suggest that more com-
plex tasks using active sling-based exercises could have
a further beneficial short-term effect on knee flexion
ROM compared to conventional CPM therapy. A clinic-
ally relevant difference between groups was found in pFL.
The ST is easy to carry out during hospital stay and is less
expensive than CPM therapy. Since the cost-effectiveness
could be increased while even improving the quality of
clinical results, the application of an ST therapy in the
post-operative phase can be recommended as part of the
early post-operative rehabilitation management. Against
the background of some methodological limitations, the
results of the present study should be interpreted with
caution and could be strengthened after a replication
study is carried out on a larger sample set.Competing interests
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